Catherine Forconi to Malaria, Falciparum
This is a "connection" page, showing publications Catherine Forconi has written about Malaria, Falciparum.
Connection Strength
2.343
-
Okoth SA, Tonui RK, Maina TK, Agwati E, Oduor CI, Racenet Z, M'Bana V, Njuguna FM, Keitany KK, Chepsiror D, Ayieko C, Moormann AM, Kinyua AW, Forconi CS. The impact of malaria-induced neutrophil subset shift and a link to Burkitt lymphoma. PLoS One. 2026; 21(6):e0348729.
Score: 0.794
-
Forconi CS, Nixon C, Wu HW, Odwar B, Pond-Tor S, Ong'echa JM, Kurtis JD, Moormann AM. T-follicular helper cell profiles differ by malaria antigen and for children compared to adults. Elife. 2025 May 22; 13.
Score: 0.739
-
Moormann AM, Nixon CE, Forconi CS. Immune effector mechanisms in malaria: An update focusing on human immunity. Parasite Immunol. 2019 08; 41(8):e12628.
Score: 0.487
-
Muriuki BM, Forconi CS, Kirwa EK, Maina TK, Ariera BO, Bailey JA, Ghansah A, Moormann AM, Ong'echa JM. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma. PLoS One. 2023; 18(8):e0275046.
Score: 0.164
-
Oluoch PO, Forconi CS, Oduor CI, Ritacco DA, Akala HM, Bailey JA, Juliano JJ, Ong'echa JM, M?nz C, Moormann AM. Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute Plasmodium falciparum Malaria Episodes. Int J Mol Sci. 2023 Apr 04; 24(7).
Score: 0.159